{"id":"W4407120774","doi":"","title":"Dreamm-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma (rrmm)","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Pembrolizumab; Medicine; Multiple myeloma; Oncology; Internal medicine; Refractory (planetary science); Cancer; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002334388,0.0009790349,0.001351527,0.0003818936,0.0003469879,0.0007171431,0.0009449819,0.0008426435,0.003826257],"category_scores_gemma":[0.001066714,0.0004918351,0.001467015,0.0003149453,0.000473929,0.0006021527,0.0005265682,0.002186048,0.0009352491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00138892,"about_ca_system_score_gemma":0.001569385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009005175,"about_ca_topic_score_gemma":0.001890572,"domain_scores_codex":[0.9992137,0.0004082462,0.00005817832,0.0001329963,0.00009362389,0.00009332543],"domain_scores_gemma":[0.9991587,0.000126614,0.0002110302,0.00007231606,0.00006132493,0.0003699924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7070542,0.04911317,0.02778705,0.001531344,0.002999537,0.0003467563,0.000397552,0.005273139,0.0520157,0.0003171889,0.005686786,0.1474775],"study_design_scores_gemma":[0.2336921,0.6957124,0.05027543,0.00006319171,0.001066795,0.0005711256,0.00008224839,0.002708051,0.009013982,0.0002726388,0.006492709,0.00004933414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900398,0.002246917,0.0005438435,0.0003894195,0.00007357643,0.002407852,0.002126784,0.00009975705,0.002072054],"genre_scores_gemma":[0.9883433,0.0007886265,0.002359909,0.0004830704,0.00009933248,0.002748303,0.002765016,0.00002041081,0.002392142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003826257,"threshold_uncertainty_score":0.0128001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2106506011008814,"score_gpt":0.5302432956176063,"score_spread":0.3195926945167249,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}